Evidence map›Paper›PMID 33238298›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Household Prevalence of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale in the Democratic Republic of the Congo, 2013-2014.

Cedar L Mitchell, Hillary M Topazian, Nicholas F Brazeau, Molly Deutsch-Feldman, Jeremie Muwonga, Eric Sompwe, Antoinette K Tshefu, Melchior K Mwandagalirwa, Jonathan B Parr, Jonathan J Juliano

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Cedar L MitchellDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Hillary M TopazianDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Nicholas F BrazeauDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Molly Deutsch-FeldmanDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Jeremie MuwongaProgramme National de la Lutte Contre le SIDA, Kinshasa, Democratic Republic of Congo.
Eric SompweProgramme National de la Lutte Contre le Paludisme, Kinshasa, Democratic Republic of Congo.
Antoinette K TshefuKinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Melchior K MwandagalirwaKinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jonathan B ParrDivision of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Jonathan J JulianoDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID 0000-0002-0591-0850
University of North Carolina at Chapel Hill · USProgramme National Multisectoriel de Lutte contre le sida · CDUniversity of Kinshasa · CD

Funding

Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
Tracking the flow of malaria parasites and drug resistance within the DRC and across its bordersR01AI139520 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BAILEY, JEFFREY A. · 2018 to 2023
$3.6M
Collaborative Research: Impacts of the African Origin of Plasmodium vivax on Contemporary Parasite PopulationsR01TW010870 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2017 to 2021
$2.4M
Mentoring in Translational Malaria GenomicsK24AI134990 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jonathan J Juliano · 2018 to 2026
$1.6M
Identifying the Distribution, Origin, and Threat of Plasmodium vivax in the DRCF30AI143172 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BRAZEAU, NICHOLAS FORD · 2019 to 2022
$171k
FIC NIH HHS R01 TW010870NIAID NIH HHS F30 AI143172NIAID NIH HHS K24 AI134990NIAID NIH HHS R01 AI139520NIAID NIH HHS T32 AI070114
6 · The paper itself

Abstract

In a cross-sectional molecular study in the Democratic Republic of the Congo, 78% of households had ≥1 member infected with Plasmodium falciparum, Plasmodium vivax, and/or Plasmodium ovale spp.; 47% of children and 33% of adults tested positive for ≥1 species. Risk factors varied by species and age group.

Indexed as

Malaria, FalciparumPlasmodium ovaleAdultChildCross-Sectional StudiesDemocratic Republic of the CongoHumansPlasmodium falciparumPlasmodium vivaxPrevalencehousehold prevalence in the DRCP. falciparumP. vivax and P. ovale

Identifiers

PMID33238298
PMCPMC8664425
OpenAlexW3106775980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.